News

Osborne Clarke advises Science Create Ventures, Foresight Williams Technology and BGF as Forefront RF launches into global smartphone market with investor-backed revolutionary new chip


Written on 11 August 2021

International legal practice Osborne Clarke has advised Science Create Ventures, Foresight Williams Technology and BGF on their involvement in Forefront RF’s initial £1.5m investment round, which  also included The Cambridge Angels. This first round of investment represents a strong vote of confidence in the company and will enable Forefront RF to recruit the world-class team necessary to accelerate the launch of its products.

Forefront RF, a Cambridge-based fabless semiconductor company, is set to change the way global smartphones, wearables and IoT Devices are designed. The Forefront RF chip enables connected devices to operate across the increasingly wide range of 3G to 6G mobile telephony frequency bands. Forefront RF’s cancellation technology redesigns the radio frequency (RF) system in a wireless device, enabling manufacturers to simplify the design and delivery of frequency agnostic products, whilst reducing cost and supply chain waste.

The chip uses Forefront RF’s Adaptive Passive Cancellation (APC) technology, similar to that used in noise-cancelling headphones. Forefront RF’s APC chip replaces the banks of RF filters and switches with a low cost, tuneable RF circuit. The component uses embedded software to maintain the accuracy of unique passive self-interference cancellation circuits. This enables a smartphone’s receiver to “hear” the weakest signals while transmitting at full power.

The Osborne Clarke team was made up of Partner Matthew Edwards, Associate Director James Taylor and Associate Krish Mistry (all Corporate) and Senior Associate Lara Flynn (Employment).

The team also previously advised Science Creates Ventures on the launch of Science Creates Ventures EIS Fund 1, a new early-stage deep tech investment fund that focuses on technologies with the potential to improve healthcare, quality of life, and the environment, as well as Science Creates Ventures’ investments into CytoSeek and Carbometrics.

Osborne Clarke’s international venture capital practice is widely recognized as a leading European law firm for companies operating in tech-enabled industries. The Venture Capital team is ranked tier one by The Legal 500 and has experts across London, the Thames Valley and Bristol. It has an outstanding track record advising start-ups, global market leaders, angel investors and institutional VC/growth capital investors on funding rounds, follow-on rounds, venture debt facilities, IPOs, trade sales and buy & build projects.

Evolving and disruptive technologies are changing how businesses operate, compete and evolve, creating extraordinary, transformative opportunities. Osborne Clarke is at the forefront of advising on ground-breaking transformations. Visit our Digital Transformation pages to find out more.